| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 02/09/2010 | CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors |
| 02/04/2010 | US20100028807 Imide Compound and Chemically Amplified Resist Composition Containing The Same |
| 02/03/2010 | EP2149560A1 1-substituted tetrahydroisoquinoline compound |
| 02/03/2010 | EP2148864A2 Fused-ring heterocycle opioids |
| 02/03/2010 | CN101638389A Polyamine derivative containing naphthalimide structure, preparation method and application thereof |
| 02/03/2010 | CN101638388A Imide compound and chemically amplified resist composition containing the same |
| 02/02/2010 | US7655085 Such as 3'-phenyl-2-methyl-4(anthraquinoneamino)-1,9-anthrapyridone; useful as colorants in resin and are resistant to degradation and color shift when processed with resins at high temperatures |
| 02/02/2010 | CA2401626C Process for the manufacture of 1,8-naphthalimide |
| 02/02/2010 | CA2324418C Novel opiate compounds, methods of making and methods of use |
| 02/02/2010 | CA2316172C Indole derivatives as inhibitors of factor xa |
| 01/28/2010 | WO2010011619A1 Large substituent, non-phenolic amine opioids |
| 01/28/2010 | WO2009120774A8 Method of preparing huperzine a and derivatives thereof |
| 01/28/2010 | US20100022572 Novel spiro compound and medicine comprising the same |
| 01/28/2010 | US20100022021 New azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions |
| 01/28/2010 | CA2731429A1 Large substituent, non-phenolic amine opioids |
| 01/27/2010 | CN101633640A Naphthalimide derivative |
| 01/27/2010 | CN100586244C Compound, charge transporting material and organic electroluminescent element |
| 01/26/2010 | US7652141 Immunosuppressants, analgesics, antiinflammatory agents |
| 01/26/2010 | US7652028 Inflammatory disease, reperfusion injury, diabetes mellitus, reoxygenation injury resulting from organ transplantation, ischemia, neurodegenerative disease, renal failure, cardiovascular disease, cancer, cardiomyopathy, retinopathy, nephropathy, neuropathy, erectile dysfunction or urinary incontinence |
| 01/26/2010 | US7652021 (2S)-4,4-difluoro-1-{N-[3-(pyrimidin-2-ylamino)-1-adamantyl]glycyl}pyrrolidine-2-carbonitrile; dipeptidyl peptidase IV enzyme inhibitors; non-insulin dependent diabetes mellitus |
| 01/26/2010 | CA2338854C Nitric esters and nitrate salts of specific drugs |
| 01/26/2010 | CA2303934C Tetrazole-containing rapamycin analogs with shortened half-lives |
| 01/21/2010 | WO2010007794A1 Novel spiro compound, and pharmaceutical preparation comprising the same |
| 01/21/2010 | WO2010007756A1 Pyridine derivative having ttk inhibition activity |
| 01/21/2010 | US20100016349 Pseudoazulenyl nitrones |
| 01/21/2010 | US20100015410 Anthrapyridone compound, salt thereof, magenta ink composition and colored product |
| 01/21/2010 | US20100012931 Polycyclic compounds and organic electroluminescence device employing the same |
| 01/20/2010 | CN101628893A 14-hydroxyl sinomenine derivatives, synthesis method thereof and use thereof |
| 01/19/2010 | US7649056 Triamantane diamondoid nucleus |
| 01/19/2010 | US7649014 Inhibit uncoupling protein-2 (UCP2); treating deficient first-phase insulin secretion, non-insulin dependent diabetes mellitus, and ischemia |
| 01/19/2010 | US7648995 R(—)-11-hydroxyaporphine derivatives and uses thereof |
| 01/19/2010 | CA2315897C Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them |
| 01/14/2010 | US20100010225 Isoquinuclidine derivative and method for manufacturing 1-cyclohexene-1-carboxylic acid derivative using the same |
| 01/14/2010 | US20100009960 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 01/14/2010 | US20100009927 Anti-Inflammatory and Anti-Allergy Extracts from Nettle |
| 01/13/2010 | CN101627014A Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for parkinson's disease prevention or treatment |
| 01/12/2010 | CA2391643C Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| 01/12/2010 | CA2306428C 3-oxo-2(h)-1,2,4 - triazine derivatives as ligands of 5ht1a receptors |
| 01/07/2010 | US20100004455 Method for producing piperidin-4-one derivative |
| 01/07/2010 | US20100004278 Dextromethorphan hydrochloride |
| 01/07/2010 | US20100004277 Compounds and methods for modulating protein trafficking |
| 01/06/2010 | EP2139861A1 Benzimidazoles with a hetero spiro-decane residue as npy-y5 antagonists |
| 01/06/2010 | EP2139857A1 Sub-type selective azabicycloalkane derivatives |
| 01/06/2010 | CN101619040A Aporphine compound, medicinal composition thereof and application thereof |
| 01/06/2010 | CN101619039A 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-cycloocta[b]pyridine (blonanserin, Blonanserin) and composition thereof |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 12/31/2009 | US20090326228 Compositions containing ionic liquids and their uses, in particular in organic synthesis |
| 12/31/2009 | US20090324900 Ink composition and colored product |
| 12/31/2009 | US20090320216 hair dyes contains naphthylimide thiol or disulphide thiol groups; resistant and visible lightening effect on dark keratin fibres; cosmetics |
| 12/30/2009 | EP2137156A1 Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for parkinson's disease prevention or treatment |
| 12/30/2009 | CN100575353C Preparation method of methyl thienotetrahydropyridinacetate |
| 12/30/2009 | CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 12/24/2009 | US20090318695 Processes for the preparation of varenicline and intermediates thereof |
| 12/24/2009 | US20090318694 Cross-Linked Amine Compounds and Agents for Pest Control |
| 12/24/2009 | US20090318491 Cytisine and Acetylcholine Analogs and Methods of Treating Mood Disorders |
| 12/24/2009 | US20090318489 Aporphine compounds and pharmaceutical use thereof |
| 12/23/2009 | WO2009152577A1 Process for the synthesis of n-demethylated morphinane compounds |
| 12/23/2009 | WO2008107777A3 Improved method for the preparation of desloratadine with reduced levels of organic solvents |
| 12/23/2009 | EP2134692A2 Quinoline derivatives and pharmaceutical compositions comprising them for selectin inhibition |
| 12/23/2009 | CA2727944A1 Process for the synthesis of n-demethylated morphinane compounds |
| 12/22/2009 | US7635702 Imidazole compounds as transforming growth factor (TGF) inhibitors |
| 12/22/2009 | CA2474460C Pyridine- and quinoline-derivatives |
| 12/22/2009 | CA2405593C Macrolides |
| 12/17/2009 | US20090312364 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/17/2009 | US20090312363 Bifunctional histone deacetylase inhibitors |
| 12/17/2009 | US20090312362 Inhibitors of the unfolded protein response and methods for their use |
| 12/16/2009 | EP1451194B2 Preparation of levofloxacin hemihydrate |
| 12/16/2009 | CN101602727A Preparation method of huperzine A |
| 12/16/2009 | CN101602726A A 12H-benzo [4,5] capram [1,2-b] quinoline compounds and preparation thereof |
| 12/15/2009 | US7632975 Process for the synthesis of arylfluorenes and analogs thereof |
| 12/15/2009 | US7632844 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors |
| 12/15/2009 | US7632578 Containing imidazo-pyridine compound |
| 12/10/2009 | US20090306382 Cationic alkoxyamines |
| 12/10/2009 | US20090305433 Water-Soluble Rhodamine Dye Conjugates |
| 12/09/2009 | EP2130820A1 Antipruritics |
| 12/09/2009 | EP1678172B1 Azabicyclic compounds for relieving pain and treating central nervous system disorders |
| 12/09/2009 | CN101597260A Novel muscarinic receptor antagonist and application thereof |
| 12/09/2009 | CN100566714C Compositions of huperzia serrata alkaloids comprising huperzine A and huperzine B and preparation thereof |
| 12/08/2009 | US7629468 Neuroprotectants, analgesics or anticonvulsants |
| 12/08/2009 | US7629467 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 12/08/2009 | US7629357 Antihypoxic agents; adjust concentration of erythropoietin concentration in blood; strokes; antiepileptic agents; neurodegenerative disease ; liver disorders; antiischemic agents |
| 12/08/2009 | CA2522180C 2-azabicyclo[3.3.1]nonane derivatives as opioid receptor antagonists |
| 12/08/2009 | CA2485916C Non-nucleoside reverse transcriptase inhibitors |
| 12/08/2009 | CA2361525C Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| 12/03/2009 | WO2009146288A1 Processes and compounds for the preparation of normorphinans |
| 12/03/2009 | US20090295275 Compounds for organic electronic devices |
| 12/03/2009 | CA2726220A1 Processes and compounds for the preparation of normorphinans |
| 12/02/2009 | EP2128137A1 Selective m4 receptor antagonist and its medical use |
| 12/02/2009 | EP2128135A1 Method for synthesis of nitroxyl radical |
| 12/02/2009 | EP1812399B1 Opiate intermediates and methods of synthesis |
| 12/02/2009 | EP1626050B1 Sulfur-containing naphthoylimide derivatives |
| 12/02/2009 | EP1581477B1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 12/02/2009 | CN101591294A Method for converting aconite diester-type alkaloids into ester-type alkaloids |
| 12/02/2009 | CN101591293A Method for converting diester-type and ester-type aconite alkaloids into monoester pyrolysis-type alkaloids |
| 12/02/2009 | CN101591292A Method for synthesizing N-alkyl-3,4-perylene dianhydride carboxylic acid mono imide |
| 12/01/2009 | US7625929 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 12/01/2009 | US7625921 Bridged ring compounds based on nitrogen-containing rings such as 5,10-dihydro-5,10-ethanobenzo(g)quinoline; treating obesity, diabetes and inflammatory or immune associated diseases; nuclear factor kappa beta (NF-KB) |
| 12/01/2009 | US7625920 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 12/01/2009 | US7625919 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia |